1.16
-0.05 (-4.13%)
-0.05 (-4.13%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 831,133 |
|
|||||
| News | - | ||||||
| Day High | 1.21 | Low High |
|||||
| Day Low | 1.12 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ampio Pharmaceuticals Inc | AMPE | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.05 | -4.13% | 1.16 | 16:33:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.15 | 1.12 | 1.21 | 1.16 | 1.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,882 | 831,133 | $ 1.16 | $ 963,794 | - | 0.84 - 2.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:00:00 | 70,645 | $ 1.16 | USD |
Period:
Draw Mode:
Ampio Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 234.47M | 202.13M | 199.52M | $ - | $ - | -0.10 | -15.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 2.45M | 2.30% |
Ampio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMPE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.28 | 1.07 | 1.17 | 1,186,842 | 0.01 | 0.87% |
| 1 Month | 1.59 | 1.67 | 1.07 | 1.37 | 1,041,085 | -0.43 | -27.04% |
| 3 Months | 1.73 | 1.83 | 1.07 | 1.58 | 1,156,244 | -0.57 | -32.95% |
| 6 Months | 1.82 | 1.98 | 1.07 | 1.62 | 1,498,390 | -0.66 | -36.26% |
| 1 Year | 0.84 | 2.98 | 0.84 | 1.77 | 3,003,117 | 0.32 | 38.1% |
| 3 Years | 0.57 | 2.98 | 0.26 | 1.21 | 2,048,001 | 0.59 | 103.51% |
| 5 Years | 0.78 | 4.9499 | 0.26 | 1.28 | 1,640,105 | 0.38 | 48.72% |
Ampio Pharmaceuticals Description
| Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress. |
